Bellato, Renelen .
HRN: 15-64-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
CEFUROXIME 500MG (TAB)
04/26/2025
05/03/2025
ORAL
500mg
BID
S/P NSD; Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes